Skip to main content

Want a detailed portfolio tracker?

Performance analysis of Edgewise Therapeutics (EWTX)

Annual Return

Over the past 3 years, EWTX has had an average annual return of +72.84%, outperforming the benchmark SPY, which returned +19.63% annual.

Over the past 5 years, EWTX has had an average annual return of +14.07%, outperforming the benchmark SPY, which returned +12.73% annual.

Since Mar 26, 2021, EWTX has had an average annual return of +5.34%, underperforming the benchmark SPY, which returned +14.22% annual.

202620252024202320222021
+59.49%-7.06%+144.04%+22.38%-41.49%-49.07%

Monthly Return

YearJanFebMarAprMayJunJulAugSepOctNovDecAnnually Total
2026+13.43%+8.14%+3.48%-1.71%+10.34%+18.93%-2.58%+59.49%
2025+4.94%-6.61%-15.93%-25.45%-12.93%-8.19%+8.76%+0.63%+13.05%+12.69%+42.46%-4.70%-7.06%
2024+62.96%-8.41%+11.70%-1.64%-4.52%+5.13%-5.43%+10.09%+42.35%+25.77%-1.70%-19.09%+144.04%
2023+14.43%-6.36%-30.38%+31.49%+15.40%-23.42%-5.92%-14.28%-8.31%+11.68%-4.97%+79.92%+22.38%
2022-11.00%-13.30%-17.74%-17.72%-21.69%+27.36%+21.49%+4.25%-2.38%-3.35%-5.90%-0.10%-41.49%
2021+8.33%-11.87%+0.80%-26.11%-17.90%-9.54%+4.79%-0.60%+5.58%-12.30%-49.07%

Drawdown analysis of Edgewise Therapeutics (EWTX)

The maximum drawdown for the EWTX was -84.69%, occurring on Nov 10, 2023. Recovery took 248 trading sessions.

The current EWTX drawdown is -18.14%.

Since Mar 26, 2021 EWTX has experienced the following drawdowns:

  • 50% or more: 2 times
  • 40% or more: 2 times
  • 30% or more: 2 times
  • 20% or more: 3 times
  • 10% or more: 5 times
DepthStartTo BottomBottomTo RecoverEndTotal
-84.69%Mar 29, 2021661Nov 10, 2023248Nov 6, 2024909
-68.81%Nov 6, 2024106Apr 11, 2025266May 5, 2026372
-21.02%Jul 9, 20265Jul 16, 2026OngoingOngoingOngoing
-18.23%Jun 1, 20267Jun 10, 20269Jun 24, 202616
-17.31%May 5, 202610May 19, 20268Jun 1, 202618
-7.45%Jun 24, 20265Jul 1, 20263Jul 7, 20268